Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovative Pharmaceutical Biotech ( (HK:0399) ) has provided an announcement.
Innovative Pharmaceutical Biotech Limited has announced the issuance of new shares under a general mandate through two subscription agreements. The company plans to issue a total of 90,000,000 shares to two subscribers at a price of HK$0.312 per share, raising approximately HK$28,080,000 in gross proceeds. The funds are intended for general working capital, and the completion of the subscriptions is subject to certain conditions. This move is expected to slightly increase the company’s share capital and provide additional financial resources for its operations.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical solutions.
Average Trading Volume: 6,378,261
Technical Sentiment Signal: Buy
Current Market Cap: HK$461.4M
See more insights into 0399 stock on TipRanks’ Stock Analysis page.